153 related articles for article (PubMed ID: 11425950)
1. The nigrostriatal dopaminergic system in familial early onset parkinsonism with parkin mutations.
Portman AT; Giladi N; Leenders KL; Maguire P; Veenma-van der Duin L; Swart J; Pruim J; Simon ES; Hassin-Baer S; Korczyn AD
Neurology; 2001 Jun; 56(12):1759-62. PubMed ID: 11425950
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene.
Hilker R; Klein C; Ghaemi M; Kis B; Strotmann T; Ozelius LJ; Lenz O; Vieregge P; Herholz K; Heiss WD; Pramstaller PP
Ann Neurol; 2001 Mar; 49(3):367-76. PubMed ID: 11261512
[TBL] [Abstract][Full Text] [Related]
3. Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkin disease.
Varrone A; Pellecchia MT; Amboni M; Sansone V; Salvatore E; Ghezzi D; Garavaglia B; Brice A; Brunetti A; Bonavita V; De Michele G; Salvatore M; Pappatà S; Barone P
Neurology; 2004 Dec; 63(11):2097-103. PubMed ID: 15596756
[TBL] [Abstract][Full Text] [Related]
4. [18 F]-dopa PET study in patients with juvenile-onset PD and parkin gene mutations.
Broussolle E; Lücking CB; Ginovart N; Pollak P; Remy P; Dürr A
Neurology; 2000 Sep; 55(6):877-9. PubMed ID: 10994015
[TBL] [Abstract][Full Text] [Related]
5. [18F]-Dopa positron emission tomography imaging in early-stage, non-parkin juvenile parkinsonism.
Pal PK; Leung J; Hedrich K; Samii A; Lieberman A; Nausieda PA; Calne DB; Breakefield XO; Klein C; Stoessl AJ
Mov Disord; 2002 Jul; 17(4):789-94. PubMed ID: 12210877
[TBL] [Abstract][Full Text] [Related]
6. Progression of nigrostriatal dysfunction in a parkin kindred: an [18F]dopa PET and clinical study.
Khan NL; Brooks DJ; Pavese N; Sweeney MG; Wood NW; Lees AJ; Piccini P
Brain; 2002 Oct; 125(Pt 10):2248-56. PubMed ID: 12244082
[TBL] [Abstract][Full Text] [Related]
7. Parkin mutations in a patient with hemiparkinsonism-hemiatrophy: a clinical-genetic and PET study.
Pramstaller PP; Künig G; Leenders K; Kann M; Hedrich K; Vieregge P; Goetz CG; Klein C
Neurology; 2002 Mar; 58(5):808-10. PubMed ID: 11889248
[TBL] [Abstract][Full Text] [Related]
8. Role of parkin mutations in 111 community-based patients with early-onset parkinsonism.
Kann M; Jacobs H; Mohrmann K; Schumacher K; Hedrich K; Garrels J; Wiegers K; Schwinger E; Pramstaller PP; Breakefield XO; Ozelius LJ; Vieregge P; Klein C
Ann Neurol; 2002 May; 51(5):621-5. PubMed ID: 12112109
[TBL] [Abstract][Full Text] [Related]
9. The striatal dopaminergic deficit is dependent on the number of mutant alleles in a family with mutations in the parkin gene: evidence for enzymatic parkin function in humans.
Hilker R; Klein C; Hedrich K; Ozelius LJ; Vieregge P; Herholz K; Pramstaller PP; Heiss WD
Neurosci Lett; 2002 Apr; 323(1):50-4. PubMed ID: 11911988
[TBL] [Abstract][Full Text] [Related]
10. A multitracer dopaminergic PET study of young-onset parkinsonian patients with and without parkin gene mutations.
Ribeiro MJ; Thobois S; Lohmann E; du Montcel ST; Lesage S; Pelissolo A; Dubois B; Mallet L; Pollak P; Agid Y; Broussolle E; Brice A; Remy P;
J Nucl Med; 2009 Aug; 50(8):1244-50. PubMed ID: 19617340
[TBL] [Abstract][Full Text] [Related]
11. New mutation (R42P) of the parkin gene in the ubiquitinlike domain associated with parkinsonism.
Terreni L; Calabrese E; Calella AM; Forloni G; Mariani C
Neurology; 2001 Feb; 56(4):463-6. PubMed ID: 11222788
[TBL] [Abstract][Full Text] [Related]
12. Young-onset Parkinson disease with and without parkin gene mutations: a fluorodopa F 18 positron emission tomography study.
Thobois S; Ribeiro MJ; Lohmann E; Dürr A; Pollak P; Rascol O; Guillouet S; Chapoy E; Costes N; Agid Y; Remy P; Brice A; Broussolle E;
Arch Neurol; 2003 May; 60(5):713-8. PubMed ID: 12756135
[TBL] [Abstract][Full Text] [Related]
13. An apparently sporadic case with parkin gene mutation in a Korean woman.
Jeon BS; Kim JM; Lee DS; Hattori N; Mizuno Y
Arch Neurol; 2001 Jun; 58(6):988-9. PubMed ID: 11405814
[TBL] [Abstract][Full Text] [Related]
14. Nigrostriatal dysfunction in homozygous and heterozygous parkin gene carriers: an 18F-dopa PET progression study.
Pavese N; Khan NL; Scherfler C; Cohen L; Brooks DJ; Wood NW; Bhatia KP; Quinn NP; Lees AJ; Piccini P
Mov Disord; 2009 Nov; 24(15):2260-6. PubMed ID: 19845000
[TBL] [Abstract][Full Text] [Related]
15. Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations.
van de Warrenburg BP; Lammens M; Lücking CB; Denèfle P; Wesseling P; Booij J; Praamstra P; Quinn N; Brice A; Horstink MW
Neurology; 2001 Feb; 56(4):555-7. PubMed ID: 11222808
[TBL] [Abstract][Full Text] [Related]
16. Parkin mutations and early onset parkinsonism.
Morrison KE
Brain; 2003 Jun; 126(Pt 6):1250-1. PubMed ID: 12764048
[No Abstract] [Full Text] [Related]
17. Clinical and genetic evaluation of 8 Polish families with levodopa-responsive parkinsonism.
Krygowska-Wajs A; Kachergus JM; Hulihan MM; Farrer MJ; Searcy JA; Booij J; Berendse HW; Wolters ECh; Wszolek ZK
J Neural Transm (Vienna); 2005 Nov; 112(11):1487-502. PubMed ID: 15785861
[TBL] [Abstract][Full Text] [Related]
18. Parkin mutations are frequent in patients with isolated early-onset parkinsonism.
Periquet M; Latouche M; Lohmann E; Rawal N; De Michele G; Ricard S; Teive H; Fraix V; Vidailhet M; Nicholl D; Barone P; Wood NW; Raskin S; Deleuze JF; Agid Y; Dürr A; Brice A; ;
Brain; 2003 Jun; 126(Pt 6):1271-8. PubMed ID: 12764050
[TBL] [Abstract][Full Text] [Related]
19. Homozygous deletion mutation of the parkin gene in patients with atypical parkinsonism.
Kuroda Y; Mitsui T; Akaike M; Azuma H; Matsumoto T
J Neurol Neurosurg Psychiatry; 2001 Aug; 71(2):231-4. PubMed ID: 11459900
[TBL] [Abstract][Full Text] [Related]
20. Homozygous exon 4 deletion in parkin gene in a Korean family with autosomal recessive early onset parkinsonism.
Kim JS; Lee KS; Kim YI; Lee KH; Kim HT
Yonsei Med J; 2003 Apr; 44(2):336-9. PubMed ID: 12728478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
